Physician profile
Brigitte D King
NPI 1780666305
$1,749.01
in general payments reported to CMS, 2019-2025
32 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $347 · 2021: $151 · 2022: $64.86 · 2023: $176 · 2024: $234 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $263.60 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $164.77 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $151.77 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $122.74 | 2019-2025 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.16 | 2020-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.22 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $108.43 | 2019-2020 | |
| Dexcom, INC. | $74.03 | 2024-2025 | Dexcom G6 Transmitter |
| Inogen, INC. | $46.53 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merck Sharp & Dohme LLC | $42.27 | 2019-2025 | Capvaxive |
| Otsuka America Pharmaceutical, INC. | $39.95 | 2023-2025 | Rexulti |
| Bausch Health US, LLC | $39.56 | 2021 | |
| Mylan Specialty L.P. | $39.48 | 2020 | |
| Sanofi-Aventis U.S. LLC | $38.47 | 2019 | |
| Ibsa Pharma INC. | $33.98 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $33.69 | 2020 | |
| Alexion Pharmaceuticals, INC. | $33.12 | 2021 | |
| Insulet Corporation | $32.22 | 2020 | |
| Exact Sciences Corporation | $30.38 | 2024-2025 | Cologuard Collection Kit |
| Allergan, INC. | $27.15 | 2019-2020 | |
| Glaxosmithkline, LLC. | $25.89 | 2020 | |
| Harmony Biosciences LLC | $23.95 | 2023 | Wakix |
| Phathom Pharmaceuticals, INC. | $18.82 | 2024 | Voquezna |
| Ferring Pharmaceuticals INC. | $18.54 | 2024 | Rebyota |
| Abbott Laboratories | $16.96 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $16.91 | 2022 | |
| Abbvie INC. | $15.59 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.02 | 2019 | |
| Horizon Therapeutics Plc | $12.75 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.94 | 2021 | |
| Esperion Therapeutics, INC. | $11.82 | 2020 | |
| Amarin Pharma, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigitte King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.